Epidemiology and management of epilepsy in Hong Kong: an overview
- PMID: 15121133
- DOI: 10.1016/S1059-1311(03)00186-9
Epidemiology and management of epilepsy in Hong Kong: an overview
Abstract
Over half of the estimated 50 million people with epilepsy live in Asia, but there has been limited information on the epidemiology, aetiology and management of epilepsy from this region. In this article, we summarise some of the main problems faced by patients and the current treatment options available in an urban area of China.
Similar articles
-
An epidemiological study of epilepsy in Hong Kong SAR, China.Seizure. 2008 Jul;17(5):457-64. doi: 10.1016/j.seizure.2007.12.005. Epub 2008 Feb 7. Seizure. 2008. PMID: 18261935
-
Utilization of antiepileptic drugs in Hong Kong children.Pediatr Neurol. 2012 May;46(5):281-6. doi: 10.1016/j.pediatrneurol.2012.02.019. Pediatr Neurol. 2012. PMID: 22520348
-
A prevalence study of epilepsy in Hong Kong.Hong Kong Med J. 2003 Aug;9(4):252-7. Hong Kong Med J. 2003. PMID: 12904612
-
Epilepsy in Hong Kong: a literature review.Hong Kong Med J. 2004 Jun;10(3):185-9. Hong Kong Med J. 2004. PMID: 15181223 Review.
-
Epilepsy in Asia: Disease burden, management barriers, and challenges.Epilepsia. 2019 Mar;60 Suppl 1:7-21. doi: 10.1111/epi.14458. Epub 2018 Jun 28. Epilepsia. 2019. PMID: 29953579 Review.
Cited by
-
The assessment of the eco-toxicological effect of gabapentin on early development of zebrafish and its antioxidant system.RSC Adv. 2018 Jun 20;8(40):22777-22784. doi: 10.1039/c8ra04250k. eCollection 2018 Jun 19. RSC Adv. 2018. PMID: 35539713 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical